Historically, orthopedic surgeons have relied on Warfarin (Coumadin) to reduce the incidence of deep vein thrombosis (DVT) in post-operative total joint patients. Newer oral anticoagulants (NOACs) have enjoyed an increase in usage over the last 10 years and are being selected by more orthopedic surgeons. This articles reviews current literature and the most recent recommendations from the American College of Orthopedic Surgeons (AAOS) and the American Academy of Chest Physicians (AACP).
Fushianes GD. Review of Anticoagulation in Post-Operative Total Joint Patients. Lynchburg Journal of Medical Science. 2019; 1(2).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.